BEAM THERAPEUTICS INC BEAM
ASignal's systematic analysis rates BEAM as Bearish.
Reflects the latest available analysis · analyzed Oct 29, 2026
The case on BEAM
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong technical momentum with MACD above signal line
- Price above 20-day and 50-day moving averages
- High cash position relative to debt (current ratio 14.57x)
- Debt-to-equity ratio of 0.23x indicates low leverage
- Negative operating and gross margins
- Negative earnings and revenue growth (revenue growth YoY: -94.20%)
- Negative free cash flow of $-241.84M
- Extremely high EV/Revenue of 12.63x despite declining revenue
- Forward P/E of -6.08x indicates unprofitable earnings trajectory
- No Reddit mentions, suggesting low retail interest or visibility
See the full verdict on BEAM
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes BEAM
Most investors never get a second opinion, let alone several. ASignal runs BEAM past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.